Literature DB >> 11020876

Levels of interleukin (IL)-6, IL-8, and IL-1 receptor antagonist in the hepatic vein following liver surgery.

T Ueda1, T Sakabe, M Oka, Y Maeda, M Nishida, F Murakami, T Maekawa.   

Abstract

BACKGROUND/AIMS: The liver produces various cytokines, but local changes in the concentrations of these reaction products after liver surgery are unknown. We investigated the local changes of interleukin-6, interleukin-8 and interleukin-1 receptor antagonist after liver surgery.
METHODOLOGY: We determined levels of interleukin-6, interleukin-8, and interleukin-1 receptor antagonist in the hepatic vein and radial artery after liver resection in 13 patients. These cytokine levels in the portal vein were also measured in 6 patients.
RESULTS: Interleukin-6, interleukin-8, and interleukin-1 receptor antagonist levels were significantly increased during liver surgery (P < 0.05). The level of interleukin-6 was significantly lower in the hepatic vein than in the radial artery as well as in the portal vein at the end of the operation (P < 0.05, < 0.03). The level of interleukin-8 and interleukin-1 receptor antagonist was significantly higher in the hepatic vein than in the artery (P < 0.05).
CONCLUSIONS: Interleukin-6 may be taken up by the liver after liver surgery, and the difference between hepatic venous and peripheral arterial interleukin-6 levels may be an indicator of liver regeneration after liver resection. Interleukin-8 and interleukin-1 receptor antagonist appear to be produced in the remaining liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020876

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Gut and liver handling of interleukin-6 during liver resection in man.

Authors:  Simon A W G Dello; Johanne G Bloemen; Marcel C G van de Poll; Ronald M van Dam; Jan H M B Stoot; Maartje A J van den Broek; Wim A Buurman; Marc H A Bemelmans; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

2.  Ketamine does not inhibit interleukin-6 synthesis in hepatic resections requiring a temporary porto-arterial occlusion (Pringle manoeuvre): a controlled, prospective, randomized, double-blinded study.

Authors:  Francisco Carlos Bonofiglio; Ernesto P Molmenti; Eduardo de Santibañes
Journal:  HPB (Oxford)       Date:  2011-07-22       Impact factor: 3.647

3.  mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment.

Authors:  Suomi Mg Fouraschen; Petra E de Ruiter; Jaap Kwekkeboom; Ron Wf de Bruin; Geert Kazemier; Herold J Metselaar; Hugo W Tilanus; Luc Jw van der Laan; Jeroen de Jonge
Journal:  World J Transplant       Date:  2013-09-24

4.  Markers of liver regeneration-the role of growth factors and cytokines: a systematic review.

Authors:  Katrin Hoffmann; Alexander Johannes Nagel; Kazukata Tanabe; Juri Fuchs; Karolin Dehlke; Omid Ghamarnejad; Anastasia Lemekhova; Arianeb Mehrabi
Journal:  BMC Surg       Date:  2020-02-12       Impact factor: 2.102

5.  B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration.

Authors:  Chia-Hung Chou; Cheng-Maw Ho; Shou-Lun Lai; Chiung-Nien Chen; Yao-Ming Wu; Chia-Tung Shun; Wen-Fen Wen; Hong-Shiee Lai
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.